Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ridogrel SCHEMBL30206884 | 1.00 | TBXA2R (1.00) | TBXA2RTBXAS1 | |
| Ridogrel SCHEMBL31639193 | 1.00 | TBXA2R (1.00) | TBXA2RTBXAS1 | |
| Ridogrel SCHEMBL11709 | 1.00 | TBXA2R (1.00) | TBXA2RTBXAS1 | |
| Ridogrel SCHEMBL11710 | 1.00 | TBXA2R (1.00) | TBXA2RTBXAS1 | |
| Ridogrel SCHEMBL7564456 | 0.99 | TBXA2R (0.98) | TBXA2RTBXAS1 | |
| Ridogrel SCHEMBL7564452 | 0.99 | TBXA2R (0.98) | TBXA2RTBXAS1 | |
| Ridogrel SCHEMBL27520191 | 0.99 | TBXA2R (0.98) | TBXA2RTBXAS1 | |
| SCHEMBL13933082 | 0.87 | TBXA2R (0.77) | TBXA2RTBXAS1 | |
| SCHEMBL9601449 | 0.87 | TBXA2R (0.76) | TBXA2RTBXAS1 | |
| SCHEMBL9601444 | 0.87 | TBXA2R (0.76) | TBXA2RTBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2426 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025184468-A9 | MEASUREMENT OF URINE THROMBOXANE METABOLITES TO PREDICT SURVIVAL | UNIVERSITY OF MASSACHUSETTS (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250120908-A1 | ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE | INTELGENX CORP. (CA) | 2025-04-17 | — | — | US | claimed |
| US-12156937-B2 | Oral film formulation for modulating absorption profile | INTELGENX CORP. (CA) | 2024-12-03 | — | — | US | claimed |
| US-20230047314-A1 | ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE | INTELGENX CORP. (CA) | 2023-02-16 | — | — | US | claimed |
| US-11471406-B2 | Oral film formulation for modulating absorption profile | INTELGENX CORP. (CA) | 2022-10-18 | — | — | US | claimed |
| US-20210022991-A1 | ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE | INTELGENX CORP. (CA) | 2021-01-28 | — | — | US | claimed |
| US-10828254-B2 | Oral film formulation for modulating absorption profile | INTELGENX CORP. (CA) | 2020-11-10 | — | — | US | claimed |
| CN-107049932-B | Small molecule drug in-situ phase change gel sustained release system and preparation method thereof | 四川大学 | 2020-11-06 | — | — | CN | claimed |
| EP-3643298-A1 | IN SITU PHASE CHANGE GEL SUSTAINED-RELEASE SYSTEM FOR SMALL MOLECULE DRUG AND PREPARATION METHOD THEREOF | Sichuan University (CN) | 2020-04-29 | — | — | EP | claimed |
| CN-1179716-A | Low dose ridogrel formulations and their use for treatment of inflammatory bowel diseases | JANSSEN PHARMACEUTICA NV (BE) | 1998-04-22 | — | — | CN | claimed |
| WO-1998015265-A1 | COLONIC DELIVERY OF WEAK ACID DRUGS | DANBIOSYST UK LIMITED (GB) | 1998-04-16 | — | — | WO | claimed |
| EP-0817631-A2 | LOW DOSE RIDOGREL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-01-14 | — | — | EP | claimed |
| WO-1996030016-A2 | LOW DOSE RIDOGREL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-10-03 | — | — | WO | claimed |
| WO-1996017606-A1 | USE OF INFLAMMATORY MODULATORS IN THE TREATMENT OF CHRONIC OR RECALCITRANT SKIN DAMAGE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-06-13 | — | — | WO | claimed |
| EP-0221601-B1 | [[[(3-Pyridinyl)methylen]amino]oxy]alkanoic acids and esters | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-03-10 | — | — | EP | claimed |
| WO-1992019182-A2 | METHOD OF ATTENUATION OF NEOINTIMAL PROLIFERATION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-11-12 | — | — | WO | claimed |
| US-4963573-A | INHIBIT BIOSYNTHESIS OF THROMBOXANE A2 | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-10-16 | — | — | US | claimed |
| US-4746671-A | THROMBOXANE SYNTHETASE INHIBITION | JANSSEN PHARMACEUTICA N.V. (BE) | 1988-05-24 | — | — | US | claimed |
| EP-0221601-A1 | [[[(3-Pyridinyl)methylen]amino]oxy]alkanoic acids and esters | JANSSEN PHARMACEUTICA N.V. (BE) | 1987-05-13 | — | — | EP | claimed |